North Capital, Inc. Astrazeneca PLC Transaction History
North Capital, Inc.
- $106 Billion
- Q1 2025
A detailed history of North Capital, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, North Capital, Inc. holds 229 shares of AZN stock, worth $16,439. This represents 0.02% of its overall portfolio holdings.
Number of Shares
229Holding current value
$16,439% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,381Shares Held
478MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.33 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.94 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.69 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.72 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $222B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...